神経人工装具: 技術と世界市場

Report Overview

The global neuroprosthetics market reached $5.0 billion in 2022, should reach $5.4 billion by 2023 and $8.1 billion by 2028 with a compound annual growth rate (CAGR) of 8.3% during the forecast period of 2023-2028.

Summary:

Neuroprosthetics represent a cross-disciplinary realm bridging neuroscience and biomedical engineering. The primary objective of the field is to address impairments caused by neurological disorders, injuries or conditions present at birth by either replacing or modulating affected components of the nervous system. The global neuroprosthetics market had estimated value around $REDACTED billion in 2022. Between 2023 and 2028, the market is predicted to grow at a CAGR of REDACTED%, leading to a market value of $REDACTED billion in 2028. Given the growing elder population, increasing prevalence of neurological disorders (paralysis, amputations and neurodegenerative diseases) and higher expectations for improved quality of life among patients, the neuroprosthetics market represents a compelling opportunity in the medical device market.

The ongoing advancements in neuroscience, micro-fabrication technologies, biomaterials, neuromorphic engineering, and information and communication technologies are leading to the developing of highly sophisticated neuroprostheses, which interact with the nervous system to restore lost motor and/or sensory capabilities effectively. Device manufacturers are using advanced artificial intelligence (AI), machine learning, robotics and material and sensor technology to create prosthetic control interfaces that can restore near natural functionality. The convergence of various cutting-edge technologies (artificial intelligence, robotics and nanotechnology) with neuroprosthetics is opening up new
possibilities and expanding market potential.

The high cost of neuroprosthetic devices and limited reimbursement are key hindering factors in the market. Neuroprosthetic devices typically involve an invasive surgical procedure that may cause safety risks (hemorrhage and infection). Products require extensive physician training, limiting accessibility primarily to countries with well-established and advanced healthcare systems. These barriers collectively impact the widespread adoption and availability of neuroprosthetic technologies in the global market.

Report Scope:

This research study aims to thoroughly assess and analyze the neuroprosthetics market, revenue forecasts and future trends, globally, and to provide strategic recommendations for the success of market participants. The scope of the study is global. Current and projected market forecasts during the forecast period (2023 to 2028) are discussed. Figures for 2023 are estimated, except where actual results have been reported. This report includes forecasts by product type, application and region from 2023 through 2028.

This report also includes an analysis of leading and emerging competitors in the worldwide neuroprosthetics market. Profiles of leading product manufacturers and emerging players with novel products in development are also analyzed. This report assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment.

Report Synopsis

Report Includes:

• 32 data tables and 49 additional tables
• A comprehensive overview and an up-to-date analysis of the global market for Neuroprosthetics
• Analyses of the global market trends, with historical market revenue data (sales figures) for 2022, estimates for 2023, forecasts for 2024 and 2026, and projections of compound annual growth rates (CAGRs) through 2028
• Estimation of the actual market size and revenue forecast for global neuroprosthetics market in USD million values, and corresponding market share analysis based on product, type of stimulation technology, application, and region
• In-depth information (facts and figures) concerning the major factors influencing the progress of this market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, future prospects, and contributions to the overall market
• Discussion of ESG developments in Neuroprosthetics market, and an understanding of the importance of ESG, consumer attitudes towards sustainability, risks and opportunity assessment, and ESG followed practices by product manufacturers and industry participants
• A relevant patent analysis with significant allotments of key patent grants on Neuroprosthetics
• Review of the recent merger and acquisition (M&A) activities, venture fundings, and other impactful strategies contributing to the growth of this market
• Identification of leading and emerging competitors in the worldwide neuroprosthetics market, and analysis of competitive landscape based on recent developments, segmental revenues, and operational integration
• Company profiles of major players within the industry, including Abbott Laboratories, Boston Scientific Corp., Cochlear Ltd., Medtronic, and Sonova

Table of Contents

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology and Information Sources
Geographic Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Summary
Chapter 3 Market Overview
Overview and Definitions
Neuroprosthetics
Need for Neuroprosthetics
Types of Neuroprosthetics
Cochlear Implants
Neuroprosthetics for Movement Restoration
Deep Brain Stimulators (DBS)
Bladder and Bowel Control Implants
Visual Prosthetics
Regulatory Landscape
U.S.
Europe
Chapter 4 Market Dynamics
Drivers
Favorable Demographic Trends
Technological Advancements
Support from Regulatory Agencies
Increasing Pressure to Cut Costs
Robust Funding Environment for Biomedical Research
Unpenetrated Market
Challenges
High Cost
Technological Challenges
Safety Concerns
Privacy and Accountability Concerns
Inconsistent Reimbursement Policies
Key Factors Impacting Market
Chapter 5 Market Breakdown by Product Type
Market Overview
Cochlear Implants
Deep Brain Stimulators
Approved Indications for Deep Brain Stimulation Therapy
Bladder and Bowel Control Implants
Sacral Nerve Stimulators (SNSs)
Tibial Nerve Stimulators (TNSs)
Neuroprosthetics for Movement Restoration
Neuroprosthetics for Movement Restoration
Functional Electrical Stimulation (FES)
Brain/Computer Interface (BCI)
Neural-controlled Prosthetic Limbs
Myoelectric Prostheses
Brain-controlled Prosthetic Limbs
Current State of BCI Technology in Prosthetics
Others
Visual Prosthetics/Retinal Prosthetics
Diaphragm Pacing System/Phrenic Nerve Stimulator
Market Revenue by Product Type
Cochlear Implants
Cochlear Implants Market Revenue by Region
Deep Brain Stimulators (DBS)
DBS Market Revenue by Region
Neuroprosthetics for Movement Restoration
Neuroprosthetics for Movement Restoration Market Revenue by Region
Bladder and Bowel Control Implants
Bladder and Bowel Control Implants: Market Revenue by Region
Others
Others Market Revenue by Region
Chapter 6 Market Breakdown by Application
Market Overview
Nervous System Function Replacement
Nervous System Modulation
Market Revenue by Application
Nervous System Function Replacement
Market Revenue by Region
Nervous System Modulation
Market Revenue by Region
Chapter 7 Market Breakdown by Region
Market Overview
Market Revenue by Region
North America
Reimbursement and Insurance Coverage
Innovation Hub and Robust Funding
Encouraging Regulatory Environment
Market Demand and Adoption
Market Revenue by Product Type
Market Revenue by Application
Market Revenue by Country
Europe
Market Revenue by Product Type
Market Revenue by Application
Market Revenue by Country
Asia-Pacific
Market Revenue by Product Type
Market Revenue by Application
Market Revenue by Country
Rest of the World (RoW)
Market Revenue by Product Type
Market Revenue by Application
Chapter 8 ESG Development
Introduction to ESG
Sustainability in the Neuroprosthetics Industry: An ESG Perspective
Key ESG Issues
Industry ESG Performance Analysis
Concluding Remarks from BCC
Chapter 9 Emerging Technologies and Development
Overview
Brain Controlled Prosthetics
Prosthesis with Sensations
Artificial Intelligence (AI) Powered Neuroprosthetics
Networked Neuroprosthesis System
Miniaturized Devices and Wireless Connectivity and Powering
Chapter 10 Clinical Trials
Overview
Cochlear Implants
Neuroprosthetics for Movement Restoration
Brain Computer Interface (BCI)
Functional Electrical Stimulation (FES)
Deep Brain Stimulators (DBS)
Bladder and Bowel Control Implants
Others
Chapter 11 Competitive Intelligence
Overview
Cochlear Implants
Company Market Shares
Market Leader Product Portfolio
Deep Brain Stimulators (DBS)
Company Market Shares
Market Leader Product Portfolio
Bladder and Bowel Control Implants
Company Market Shares
Market Leader Product Portfolio
Neuroprosthetics for Movement Restoration
Key Companies Product Portfolio
Others
Mergers and Acquisitions (M&A)
Chapter 12 Company Profiles
ABBOTT LABORATORIES
AXONICS INC.
BIOVENTUS
BLACKROCK NEUROTECH
BOSTON SCIENTIFIC CORP.
COCHLEAR LTD.
CYBERDYNE INC.
MED-EL MEDICAL ELECTRONICS
MEDTRONIC
NEUROPACE INC.
PARADROMICS
SONOVA
SYNCHRON
VIVANI MEDICAL INC.
Chapter 13 Appendix

List of Tables
Summary Table : Global Market for Neuroprosthetics, by Product Type, Through 2028
Table 1 : Impairments Due to Dysfunction or Damaged Neurons
Table 2 : U.S. FDA Device Classification of Neuroprosthetics
Table 3 : Public Agency Funding/Initiatives, Neuroprosthetic Advancements
Table 4 : Funds Raised, by Selected BCI Companies
Table 5 : Factors Impacting Neuroprosthetics Market
Table 6 : BCI Signal Acquisition Technologies
Table 7 : BCI Industry Overview
Table 8 : Motor Impairments and Prevalence
Table 9 : Sensory Impairments and Prevalence
Table 10 : Global Market for Neuroprosthetics, by Product Type, Through 2028
Table 11 : Global Hearing Loss Prevalence, by WHO Region, 2019
Table 12 : Global Market for Cochlear Implants, by Region, Through 2028
Table 13 : Global Market for DBS, by Region, Through 2028
Table 14 : Global Market for Neuroprosthetics for Movement Restoration, by Region, Through 2028
Table 15 : Global Market for Bladder and Bowel Control Implants, by Region, Through 2028
Table 16 : Global Market for Other Neuroprosthetics, by Region, Through 2028
Table 17 : Global Market for Neuroprosthetics, by Application, Through 2028
Table 18 : Global Market for Neuroprosthetics for Nervous System Function Replacement, by Region, Through 2028
Table 19 : Global Market for Neuroprosthetics for Nervous System Modulation, by Region, Through 2028
Table 20 : Global Market for Neuroprosthetics, by Region, Through 2028
Table 21 : North American Market for Neuroprosthetics, by Product Type, Through 2028
Table 22 : North American Market for Neuroprosthetics, by Application, Through 2028
Table 23 : North American Market for Neuroprosthetics, by Country, Through 2028
Table 24 : European Market for Neuroprosthetics, by Product Type, Through 2028
Table 25 : European Market for Neuroprosthetics, by Application, Through 2028
Table 26 : European Market for Neuroprosthetics, by Country, Through 2028
Table 27 : Asia-Pacific Market for Neuroprosthetics, by Product Type, Through 2028
Table 28 : Asia-Pacific Market for Neuroprosthetics, by Application, Through 2028
Table 29 : Asia-Pacific Market for Neuroprosthetics, by Country, Through 2028
Table 30 : RoW Market for Neuroprosthetics, by Product Type, Through 2028
Table 31 : RoW Market for Neuroprosthetics, by Application, Through 2028
Table 32 : Critical ESG Factors in Neuroprosthetics
Table 33 : Major Neuroprosthetics Achievements: Key ESG Focus Areas
Table 34 : ESG Rankings of Major Neuroprosthetics Companies, 2023*
Table 35 : CDP Scope Card for Major Neuroprosthetics Companies, 2022
Table 36 : Selected Significant Developments in BCI Technology
Table 37 : Selected Cochlear Implants in Clinical Trial
Table 38 : Selected BCI Neuroprosthetics in Clinical Trial
Table 39 : Selected FES Neuroprosthetics in Clinical Trial
Table 40 : Selected DBS in Clinical Trial
Table 41 : Selected Bladder and Bowel Control Implants in Development
Table 42 : Selected Visual Prosthetics in Development
Table 43 : Market Leader Cochlear Implants Product Portfolio
Table 44 : Currently Available: Deep Brain Stimulators (DBSs)
Table 45 : Currently Available: Bladder and Bowel Control Implants
Table 46 : Selected Neuroprosthetics for Movement Restoration
Table 47 : Currently Available Diaphragm Pacing System
Table 48 : M&A in the Neuroprosthetics Market Jan. 2021-May 2023
Table 49 : Abbott Laboratories: Financials, 2022
Table 50 : Abbott Laboratories: Neuroprosthetics Portfolio
Table 51 : Abbott Laboratories: News/Key Developments, Jan 2021-June 2023
Table 52 : Axonics Inc.: Financials, 2022
Table 53 : Axonics Inc.: Neuroprosthetics Portfolio
Table 54 : Axonics Inc.: News/Key Developments, Jan. 2022-June 2023
Table 55 : Bioventus: Financials, 2022
Table 56 : Bioventus: Neural Prosthetics Portfolio
Table 57 : Bioventus: News/Key Developments, Jan. 2021-June 2023
Table 58 : Blackrock Neurotech: Product Portfolio
Table 59 : Blackrock Neurotech: News/Key Developments, Jan. 2021-June 2023
Table 60 : Boston Scientific Corp.: Financials, 2022
Table 61 : Boston Scientific Corp.: Neuroprosthetics Portfolio
Table 62 : Boston Scientific Corp.: News/Key Developments, Jan. 2021-June 2023
Table 63 : Cochlear Ltd.: Financials, 2022
Table 64 : Cochlear Ltd.: Neural Prosthetics Portfolio
Table 65 : Cochlear Ltd.: News/Key Developments, Jan. 2021-June 2023
Table 66 : Cyberdyne Inc.: Financials, 2022*
Table 67 : Cyberdyne Inc.: Neural Prosthetics Portfolio
Table 68 : MED EL: Neuroprosthetics Portfolio
Table 69 : Medtronic: Financials, 2022
Table 70 : Medtronic: Neuroprosthetics Portfolio
Table 71 : Medtronic: News/Key Developments, Jan. 2021-June 2023
Table 72 : NeuroPace Inc.: Financials, 2022
Table 73 : NeuroPace Inc.: Neuroprosthetic Portfolio
Table 74 : NeuroPace Inc.: News/Key Developments, Jan. 2018-June 2023
Table 75 : Paradromics: News/Key Developments, Dec. 2020-June 2023
Table 76 : Sonova: Financials, 2022
Table 77 : Sonova: Neural Prosthetics Portfolio
Table 78 : Sonova: News/Key Developments, Dec. 2020-June 2023
Table 79 : Synchron: News/Key Developments, Jan. 2020-June 2023
Table 80 : Acronyms

List of Figures
Summary Figure A : Global Market for Neuroprosthetics, by Product Type, 2020-2028
Summary Figure B : Global Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 1 : Percentage of Disability, Adults 18+, U.S., 2019
Figure 2 : Granted Breakthrough Device Designations (BDD), by Clinical Panel, As of March 31, 2023
Figure 3 : DBS Primary Treatment: Patient Shares, by Indication
Figure 4 : Leading Cause of Paralysis
Figure 5 : Stroke and Associated Burden on Healthcare System in U.S., Europe and Canada
Figure 6 : BCI Device Steps
Figure 7 : BCI Signal Acquisition Technologies, by Type
Figure 8 : Advantages of Brain-Controlled Prosthetic Limbs
Figure 9 : Global Market for Neuroprosthetics, by Product Type, 2020-2028
Figure 10 : Global Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 11 : Hearing Loss Prevalence, by Age Group, 2019
Figure 12 : Global Market for Cochlear Implants, by Region, 2020-2028
Figure 13 : Global Market Shares of Cochlear Implants, by Region, 2022
Figure 14 : Global Market for DBS, by Region, 2020-2028
Figure 15 : Global Market Shares of DBS, by Region, 2022
Figure 16 : Global Market for Neuroprosthetics for Movement Restoration, by Region, 2020-2028
Figure 17 : Global Market Shares of Neuroprosthetics for Movement Restoration, by Region, 2022
Figure 18 : Global Market for Bladder and Bowel Control Implants, by Region, 2020-2028
Figure 19 : Global Market Shares of Bladder and Bowel Control Implants, by Region, 2022
Figure 20 : Global Market for Other Neuroprosthetics, by Region, 2020-2028
Figure 21 : Global Market Shares of Other Neuroprosthetics, by Region, 2022
Figure 22 : Global Market for Neuroprosthetics, by Application, 2020-2028
Figure 23 : Global Market Shares of Neuroprosthetics, by Application, 2022
Figure 24 : Global Market for Neuroprosthetics for Nervous System Function Replacement, by Region, 2020-2028
Figure 25 : Global Market Shares of Neuroprosthetics for Nervous System Function Replacement, by Region, 2022
Figure 26 : Global Market for Neuroprosthetics for Nervous System Modulation, by Region, 2020-2028
Figure 27 : Global Market Shares of Neuroprosthetics for Nervous System Modulation, by Region, 2022
Figure 28 : Global Market for Neuroprosthetics, by Region, 2020-2028
Figure 29 : Global Market Shares of Neuroprosthetics, by Region, 2022
Figure 30 : Investment on Grants for Biomedical Research, by Region, in 2020
Figure 31 : North American Market for Neuroprosthetics, by Product Type, 2020-2028
Figure 32 : North American Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 33 : North American Market for Neuroprosthetics, by Application, 2020-2028
Figure 34 : North American Market Shares of Neuroprosthetics, by Application, 2022
Figure 35 : North American Market for Neuroprosthetics, by Country, 2020-2028
Figure 36 : European Market for Neuroprosthetics, by Product Type, 2020-2028
Figure 37 : European Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 38 : European Market for Neuroprosthetics, by Application, 2020-2028
Figure 39 : European Market Shares of Neuroprosthetics, by Application, 2022
Figure 40 : European Market for Neuroprosthetics, by Country, 2020-2028
Figure 41 : Global Aging (60+) Population, by Region, 2015-2050
Figure 42 : Asia-Pacific Market for Neuroprosthetics, by Product Type, 2020-2028
Figure 43 : Asia-Pacific Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 44 : Asia-Pacific Market for Neuroprosthetics, by Application, 2020-2028
Figure 45 : Asia-Pacific Market Shares of Neuroprosthetics, by Application, 2022
Figure 46 : Asia-Pacific Market for Neuroprosthetics, by Country, 2020-2028
Figure 47 : RoW Market for Neuroprosthetics, by Product Type, 2020-2028
Figure 48 : RoW Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 49 : RoW Market for Neuroprosthetics, by Application, 2020-2028
Figure 50 : RoW Market Shares of Neuroprosthetics, by Application, 2022
Figure 51 : Selected Factors Driving ESG
Figure 52 : How A Strong ESG Proposition Benefits Business
Figure 53 : Five Key ESG Focus Areas, Neuroprosthetics, 2022
Figure 54 : Emerging Trends/Technologies in the Neuroprosthetics Market
Figure 55 : Advantages of The Networked Neuroprosthetic (NNP) System
Figure 56 : Principle Competitive Factors in the Neuroprosthetics Market
Figure 57 : Global Market Shares of Cochlear Implants, by Manufacturer, 2022
Figure 58 : Global Market Shares of DBS, by Manufacturer, 2022
Figure 59 : Global Market Shares of Bladder and Bowel Control Implants, by Manufacturer, 2022
Figure 60 : Abbott Laboratories: Financials, 2021 and 2022
Figure 61 : Abbott Laboratories: Revenue Shares, by Business Unit, 2022
Figure 62 : Abbott Laboratories: Revenue Shares, by Region, 2022
Figure 63 : Axonics Inc.: Financials, 2021 and 2022
Figure 64 : Axonics Inc.: Revenue Shares, by Product, 2022
Figure 65 : Axonics Inc.: Revenue Shares, by Region, 2022
Figure 66 : Bioventus: Financials, 2021 and 2022
Figure 67 : Bioventus: Revenue Shares, by Business Unit, 2022
Figure 68 : Bioventus: Revenue Shares, by Region, 2022
Figure 69 : Boston Scientific Corp.: Financials, 2021 and 2022
Figure 70 : Boston Scientific Corp.: Revenue Shares, by Business Unit, 2022
Figure 71 : Boston Scientific Corp.: Revenue Shares, by Region, 2022
Figure 72 : Cochlear Ltd.: Financials, 2021 and 2022
Figure 73 : Cochlear Ltd.: Revenue Shares, by Business Segment, 2022
Figure 74 : Cochlear Ltd.: Revenue Shares, by Region, 2022
Figure 75 : Cyberdyne Inc.: Financials, 2021 and 2022
Figure 76 : Cyberdyne Inc.: Revenue Shares, by Business Type, 2022
Figure 77 : Cyberdyne Inc.: Revenue Shares, by Region, 2022
Figure 78 : Medtronic: Financials, 2021 and 2022
Figure 79 : Medtronic: Revenue Shares, by Business Unit, 2022
Figure 80 : Medtronic: Revenue Shares, by Region, 2022
Figure 81 : NeuroPace Inc.: Financials, 2021 and 2022
Figure 82 : Sonova: Financials, 2021 and 2022
Figure 83 : Sonova: Revenue Shares, by Business Unit, 2022
Figure 84 : Sonova: Revenue Shares, by Region, 2022